Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future

This publication has 10 references indexed in Scilit:

• Immunoglobulin A (IgA) Responses and IgE-Associated Inflammation along the Respiratory Tract after Mucosal but Not Systemic Immunization
  Infection and Immunity, 2001
• Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity
  Vaccine, 2001
• Nasal vaccination with attenuated Salmonella typhimurium strains expressing the Hepatitis B nucleocapsid: dose response analysis
  Vaccine, 2001
• Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization
  Vaccine, 2001
• Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults
  Vaccine, 2001
• Mucosal immunity in the lung and upper airway
  Vaccine, 2001
• The bare skin and the nose as non-invasive routes for administering peptide vaccines
  Vaccine, 2001
• DNA vaccination against respiratory influenza virus infection
  Vaccine, 2001
• Nasal immunization with E. coli verotoxin 1 (VT1)-B subunit and a nontoxic mutant of cholera toxin elicits serum neutralizing antibodies
  Vaccine, 2001
• Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen
  FEMS Immunology & Medical Microbiology, 2000